Cannabis News

Cannabis News

Latest cannabis industry news from trusted sources around the world.

Cannabis Rescheduling to Schedule III Gains Unlikely Support Across Political Spectrum
High TimesJan 3, 2026

Cannabis Rescheduling to Schedule III Gains Unlikely Support Across Political Spectrum

Cannabis rescheduling to Schedule III garners support from diverse groups, highlighting varied motivations and potential impacts on research and policy

  • Cannabis rescheduling to Schedule III gains support from diverse groups
  • The White House initiates reclassification, potentially final by 2026
  • Medical associations and Trump-linked groups praise the move for different reasons

by When Pharma and MAGA World Agree on Weed Rescheduling, Something’s Up

Cannabis Research in 2025 Highlights Innovations and Challenges

Cannabis Research in 2025 Highlights Innovations and Challenges

Cannabis research in 2025 reveals key industry trends, including cannabinoid hyperemesis syndrome insights and the effects of delta-8 THC

  • Veterans Action Council discusses cannabinoid hyperemesis syndrome
  • Mandatory warning signs for cannabis use during pregnancy studied
  • Delta-8 THC effects compared to delta-9 THC in new research

by <![CDATA[2025 Reseach Roundup]]>

Majority of Americans Support Cannabis Legalization and Reclassification, YouGov Survey Reveals

Majority of Americans Support Cannabis Legalization and Reclassification, YouGov Survey Reveals

A YouGov survey shows most Americans support cannabis legalization and reclassification, reflecting growing acceptance of its medical uses

  • 54% of Americans support recreational cannabis legalization
  • 70% approve of reclassifying cannabis for research purposes
  • 76% believe in cannabis's legitimate medical uses

by <![CDATA[Most Americans Back Cannabis Legalization, Medical Use, and Reclassification, YouGov Data Show]]>

Ally Train Transforms Cannabis Content with Unique Approach at Cough Creative
High TimesJan 2, 2026

Ally Train Transforms Cannabis Content with Unique Approach at Cough Creative

Ally Train's Cough Creative redefines cannabis content with a unique, calming approach inspired by nature documentaries, emphasizing comfort and connection

  • Ally Train of Cough Creative uses nature documentary inspiration for cannabis content
  • Her personal experience with chronic illness informs her creative approach
  • Train navigates platform restrictions while maintaining authenticity and integrity

by Finding Calm in Cannabis Content: A Conversation With Ally Train of Cough Creative

Stopping Cannabis Use Leads to Intense Dreams and Sleep Disturbances
High TimesJan 2, 2026

Stopping Cannabis Use Leads to Intense Dreams and Sleep Disturbances

Quitting cannabis may lead to intense dreams and sleep disturbances, as research explores its effects on REM sleep and tolerance

  • Quitting cannabis can lead to intense dreams and nightmares
  • Cannabis use alters the REM phase, affecting dream intensity
  • Tolerance to cannabis can cause a resurgence of symptoms upon cessation

by Withdrawal, Nightmares &#038; Dreams: What Really Happens When You Stop Smoking Weed

PhilaDelic Forum Advocates for Psychedelic Use in Treating Mental Illness
High TimesJan 2, 2026

PhilaDelic Forum Advocates for Psychedelic Use in Treating Mental Illness

The PhilaDelic Fall Forum in Philadelphia highlighted the potential of psychedelics like ibogaine and psilocybin in treating mental health disorders

  • PhilaDelic Fall Forum gathered 400 experts to discuss psychedelic treatments
  • Potential legislative changes could support ibogaine research by 2026
  • Personal stories highlighted psychedelics' impact on mental health recovery

by Trip Your Way to Better Health? Researchers See Medical Potential in Ketamine, Mushrooms and Ibogaine

Curaleaf Opens New Millcreek Dispensary in Erie, Pennsylvania

Curaleaf Opens New Millcreek Dispensary in Erie, Pennsylvania

Curaleaf has launched its new Millcreek dispensary in Erie, Pennsylvania, enhancing its retail footprint and customer experience

  • Curaleaf opens new dispensary in Erie, Pennsylvania
  • The new location offers improved layout and customer experience
  • Curaleaf now operates 18 dispensaries in Pennsylvania

by <![CDATA[New Curaleaf Millcreek Dispensary Location Opens]]>

Kentucky's First Medical Cannabis Dispensary Sells Out in One Week
High TimesDec 31, 2025

Kentucky's First Medical Cannabis Dispensary Sells Out in One Week

Kentucky's first medical cannabis dispensary sold out within a week, underscoring high demand and supply challenges in the new program

  • Kentucky's first medical cannabis dispensary sold out in one week
  • The Post Dispensary opened on December 13 and closed by December 20
  • Strict purchase limits were imposed to manage limited supply

by Legal Weed Finally Arrived in Kentucky. It Didn’t Last a Week

Dutch Customs Seize Record 60 Tonnes of Cannabis in 2025
DutchNewsDec 31, 2025

Dutch Customs Seize Record 60 Tonnes of Cannabis in 2025

Dutch customs seized a record 60 tonnes of cannabis in 2025, primarily at Rotterdam, with plans to enhance control measures against smuggling

  • Dutch customs seized 60 tonnes of cannabis in 2025
  • The majority was found at Rotterdam, with Schiphol also affected
  • Cannabis originated from the US, Canada, and Thailand

by Customs chalk up record 60 tonne cannabis haul in 2025

High Times Releases Cannabis-Themed Short Film 'Don't Be A Clown'
High TimesDec 30, 2025

High Times Releases Cannabis-Themed Short Film 'Don't Be A Clown'

High Times has released 'Don't Be A Clown,' a cannabis-themed satire by Dan Levy Dagerman, exploring humorous aspects of cannabis culture

  • High Times releases 'Don't Be A Clown,' a cannabis-themed short film
  • The film is directed by Dan Levy Dagerman and features a notable cast
  • The narrative humorously explores cannabis culture through protagonist Arty

by It’s 4:20. Watch &#8216;Don’t Be A Clown,&#8217; High Times&#8217; Weed-Themed Short Film

High Times Reemerges with Renewed Focus on Diverse Cannabis Content
High TimesDec 30, 2025

High Times Reemerges with Renewed Focus on Diverse Cannabis Content

High Times has resumed operations, focusing on diverse cannabis content and community engagement, with plans for quarterly print editions and innovative initiatives

  • High Times resumed operations on July 16, 2025, with a focus on authentic cannabis content
  • Over 500 articles from 100 contributors have been published since reopening
  • The 50th Anniversary Issue marked a significant milestone, emphasizing the publication's legacy

by High Times Is Back. Here’s What We Built in 5.5 Months

Arizona Ballot Initiative Seeks to End Legal Cannabis Sales by 2028
High TimesDec 30, 2025

Arizona Ballot Initiative Seeks to End Legal Cannabis Sales by 2028

Arizona's new ballot initiative aims to dismantle the legal cannabis market by 2028 while keeping personal use legal, sparking statewide debate

  • Arizona's initiative seeks to end legal cannabis sales by 2028
  • Personal use of cannabis would remain legal under the proposal
  • The initiative is led by Sean Noble and supported by Smart Approaches to Marijuana

by A Big Push to Ban Weed Sales in Arizona Is Just Getting Started

Bosnia and Herzegovina Legalizes Medical Cannabis, Paving Way for Regulated Use
High TimesDec 30, 2025

Bosnia and Herzegovina Legalizes Medical Cannabis, Paving Way for Regulated Use

Bosnia and Herzegovina's legalization of medical cannabis marks a pivotal shift, setting the stage for regulated therapeutic use

  • Bosnia and Herzegovina legalizes medical cannabis for therapeutic use
  • The decision ends cannabis's status as a prohibited substance
  • Lawmaker Saša Magazinović highlights the need for detailed regulations

by Bosnia and Herzegovina Legalizes Medical Cannabis—Now What?

Cannabis Industry Faces Milestones and Setbacks in 2025
High TimesDec 30, 2025

Cannabis Industry Faces Milestones and Setbacks in 2025

The cannabis industry in 2025 saw major shifts, with federal rescheduling in the U.S. and Germany leading European legalization efforts

  • President Trump initiated cannabis rescheduling to Schedule III in December 2025
  • High Times celebrated its 50th anniversary with a special edition and Cannabis Cups
  • Congress re-criminalized intoxicating hemp products, impacting the hemp industry

by The Year in Weed: 2025&#8217;s Biggest Moments

Wageningen University Researchers Revive Ancestral Cannabis Enzymes for Medical Innovation
DutchNewsDec 30, 2025

Wageningen University Researchers Revive Ancestral Cannabis Enzymes for Medical Innovation

Wageningen University researchers have revived ancestral cannabis enzymes, potentially revolutionizing medical cannabinoid production with more robust and versatile enzymes

  • Wageningen University revives ancestral cannabis enzymes for research
  • Ancestral enzymes can produce multiple cannabinoids simultaneously
  • These enzymes are more robust and easier to replicate than modern ones

by Joint research: Wageningen team resurrect ancestral cannabis

Global Cannabis Policies in 2025 Focus on Culture and Accessories Over Plant
High TimesDec 29, 2025

Global Cannabis Policies in 2025 Focus on Culture and Accessories Over Plant

In 2025, global cannabis policies shifted focus from the plant to cultural and accessory aspects, affecting markets worldwide

  • Governments targeted cannabis culture and accessories in 2025 rather than the plant itself
  • Gujarat banned rolling papers, citing public health concerns
  • Galicia imposed heavy penalties on cannabis imagery to protect minors

by 2025 Was the Year Governments Went to War With Weed Without Saying So

Medical Cannabis Advances in 2025 Highlight Opioid Alternatives and Dementia Research

Medical Cannabis Advances in 2025 Highlight Opioid Alternatives and Dementia Research

In 2025, medical cannabis research shows promise in reducing opioid use and improving dementia care, with new programs launched in Kentucky and Texas expanding access

  • Medical cannabis research in 2025 focuses on opioid reduction and dementia care
  • Kentucky launched its medical cannabis program in January 2025
  • A study highlights the need for better training for physicians on medical cannabis

by <![CDATA[2025 Medical Cannabis Roundup]]>

Third-Party Audits Enhance Compliance in the Cannabis Industry

Third-Party Audits Enhance Compliance in the Cannabis Industry

Third-party audits are crucial for enhancing compliance in the cannabis industry, helping companies proactively address regulatory challenges and build consumer trust

  • Cannabis industry faces increasing regulatory scrutiny
  • Third-party audits offer proactive compliance solutions
  • Internal audits have limitations due to bias and politics

by <![CDATA[Why Third-Party Audits Are the Most Underused Compliance Tool in the Cannabis Industry]]>

Home Cannabis Cultivation: Navigating Legalities and Choosing the Right Strains
High TimesDec 29, 2025

Home Cannabis Cultivation: Navigating Legalities and Choosing the Right Strains

Home cannabis cultivation laws vary widely across the U.S., requiring careful research before beginning. Choosing between auto-flowering and photoperiod strains is key for aspiring growers

  • Cannabis cultivation laws vary by state, affecting home growers
  • Auto-flowering strains are beginner-friendly and less labor-intensive
  • Photoperiod strains offer higher yields but require more attention

by Can I Even Grow? A Guide for the Aspiring Home Cultivator

Stormrock Attracts CBD Enthusiasts with Competitive Offers and Premium Quality
NewsweedDec 29, 2025

Stormrock Attracts CBD Enthusiasts with Competitive Offers and Premium Quality

Stormrock attracts CBD enthusiasts with competitive offers and premium quality, enhancing customer satisfaction and loyalty

  • Stormrock offers high-quality CBD products with enticing promotions
  • Customers receive free samples and bonus grams with qualifying purchases
  • Significant promotions make premium CBD accessible to a wider audience

by stormrock-cbd-offres-allechantes

DARPA Launches Project to Develop Non-Hallucinogenic Psychedelic Drugs
NewsweedDec 29, 2025

DARPA Launches Project to Develop Non-Hallucinogenic Psychedelic Drugs

DARPA launches Focused Pharma project to develop non-hallucinogenic psychedelic drugs for treating mental health conditions in military settings

  • DARPA initiates Focused Pharma to explore non-hallucinogenic psychedelics
  • Project aims to treat PTSD, depression, and anxiety without hallucinations
  • Research influenced by promising results from private clinical studies

by armee-americaine-chercher-psychedelique-non-hallucinogenes

Want to read more?

Check out our weed menu, blog and news about cannabis in 9 languages!